Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

NCT00606632 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Cell Carcinoma
Kidney Cancer

Interventions

DRUG: 124-Iodine-cG250 (124I-cG250)
PROCEDURE: CT

Sponsor

Heidelberg Pharma AG